Drug Pipeline

Fostamatinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-29 NCT05904093
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in…		 date change Primary completion pushed: 2026-05-14 -> 2027-05-14
2026-05-29 NCT05904093
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in…		 date change Completion pushed: 2026-05-14 -> 2027-05-14
Active Studies by Phase
Phase 2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06564207 Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized… Acute Respiratory Distress Syndrome Not Yet Recruiting
Phase 1
NCT06233110 Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD Chronic Graft Versus Host Disease Recruiting
NCT05904093 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in… Sickle Cell Disease Recruiting
NCT06948097 Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the… Lung Transplantation Not Yet Recruiting
Sponsors Running Fostamatinib Trials
National Heart, Lung, and Blood Institute (NHLBI) (2) Stefanie Sarantopoulos, MD, PhD. (1) Inova Health Care Services (1)
Disease Areas
Sickle Cell Disease (1) Thalassemia (1)
Get alerts when Fostamatinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free